David C. Metz

3.1k total citations · 2 hit papers
41 papers, 2.2k citations indexed

About

David C. Metz is a scholar working on Epidemiology, Gastroenterology and Surgery. According to data from OpenAlex, David C. Metz has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 14 papers in Gastroenterology and 12 papers in Surgery. Recurrent topics in David C. Metz's work include Gastroesophageal reflux and treatments (12 papers), Neuroendocrine Tumor Research Advances (12 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). David C. Metz is often cited by papers focused on Gastroesophageal reflux and treatments (12 papers), Neuroendocrine Tumor Research Advances (12 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). David C. Metz collaborates with scholars based in United States, Switzerland and Austria. David C. Metz's co-authors include Yu‐Xiao Yang, James D. Lewis, Solomon Epstein, Neil Stollman, Diane Reidy‐Lagunes, Jonathan Strosberg, Matthew H. Kulke, Pamela L. Kunz, David S. Klimstra and Lowell Anthony and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

David C. Metz

39 papers receiving 2.1k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture

2006 914 citations Yu‐Xiao Yang, James D. Lewis et al. JAMA profile →
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors

2013 426 citations Pamela L. Kunz, Diane Reidy‐Lagunes et al. Pancreas profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David C. Metz United States	18	905	900	810	738	476	41	2.2k
Tom‐Harald Edna Norway	26	35 0.0×	900 1.0×	258 0.3×	628 0.9×	151 0.3×	57	2.0k
James S. Scolapio United States	28	433 0.5×	1.4k 1.6×	310 0.4×	211 0.3×	29 0.1×	141	3.1k
Jeff Gornbein United States	16	187 0.2×	591 0.7×	379 0.5×	51 0.1×	99 0.2×	27	1.7k
P. Terry Phang Canada	30	58 0.1×	1.5k 1.7×	552 0.7×	715 1.0×	100 0.2×	125	2.7k
Wonngarm Kittanamongkolchai United States	28	112 0.1×	251 0.3×	294 0.4×	106 0.1×	43 0.1×	69	1.9k
Matthew K. Abramowitz United States	25	72 0.1×	318 0.4×	195 0.2×	137 0.2×	72 0.2×	59	2.3k
Stephen B. Vogel United States	28	378 0.4×	1.4k 1.5×	311 0.4×	538 0.7×	56 0.1×	63	2.2k
Narat Srivali United States	27	85 0.1×	336 0.4×	276 0.3×	85 0.1×	64 0.1×	91	1.8k
H J Sugerman United States	18	184 0.2×	1.4k 1.6×	161 0.2×	80 0.1×	214 0.4×	25	2.1k
Michael Larvin United Kingdom	28	233 0.3×	1.8k 2.0×	353 0.4×	1.2k 1.6×	20 0.0×	56	2.8k

Countries citing papers authored by David C. Metz

Since Specialization

Citations

This map shows the geographic impact of David C. Metz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Metz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Metz more than expected).

Fields of papers citing papers by David C. Metz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Metz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Metz. The network helps show where David C. Metz may publish in the future.

Co-authorship network of co-authors of David C. Metz

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Metz. A scholar is included among the top collaborators of David C. Metz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Metz. David C. Metz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soulen, Michael C., Rosemarie Mick, Jennifer R. Eads, et al.. (2023). Integration of Radioembolization with CapTem for Liver-Dominant G2 NETs: Long-Term Outcomes. Endocrine Abstracts. 1 indexed citations

Soulen, Michael C., Rosemarie Mick, Jennifer R. Eads, et al.. (2023). Integrated Capecitabine–Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study. CardioVascular and Interventional Radiology. 47(1). 60–68. 3 indexed citations

Metz, David C., Eric Liu, Vijay N. Joish, et al.. (2020). <p>Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome</p>. Cancer Management and Research. Volume 12. 9713–9719. 3 indexed citations

Yang, Zhaohai, et al.. (2020). Sa1150 CAN LONG TERM USE OF PROTON PUMP INHIBITORS LEAD TO GASTRIC NEUROENDOCRINE TUMOR DEVELOPMENT?. Gastroenterology. 158(6). S–291.

Beveridge, Claire, Gary W. Falk, Nitin K. Ahuja, et al.. (2019). Low Yield of Cross-Sectional Imaging in Patients With Esophagogastric Junction Outflow Obstruction. Clinical Gastroenterology and Hepatology. 18(7). 1643–1644. 14 indexed citations

Hope, Thomas A., Emily K. Bergsland, Murat Fani Bozkurt, et al.. (2017). Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors. Journal of Nuclear Medicine. 59(1). 66–74. 216 indexed citations

Riff, Brian P., Yu‐Xiao Yang, Michael C. Soulen, et al.. (2015). Peptide Receptor Radionuclide Therapy–Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors. Clinical Nuclear Medicine. 40(11). 845–850. 38 indexed citations

Korman, Louis Y., Nadim Haddad, David C. Metz, et al.. (2014). Effect of propofol anesthesia on force application during colonoscopy. Gastrointestinal Endoscopy. 79(4). 657–662. 17 indexed citations

Kunz, Pamela L., Diane Reidy‐Lagunes, Lowell Anthony, et al.. (2013). Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors. Pancreas. 42(4). 557–577. 426 indexed citations breakdown →

10.

Yang, Yu‐Xiao, Geoffrey Spencer, Sharon Schutte-Rodin, Colleen Brensinger, & David C. Metz. (2013). Gastroesophageal reflux and sleep events in obstructive sleep apnea. European Journal of Gastroenterology & Hepatology. 25(9). 1017–1023. 22 indexed citations

11.

Korman, Louis Y., Lawrence J. Brandt, David C. Metz, et al.. (2012). Segmental increases in force application during colonoscope insertion: quantitative analysis using force monitoring technology. Gastrointestinal Endoscopy. 76(4). 867–872. 10 indexed citations

12.

Yang, Yu‐Xiao, James D. Lewis, Solomon Epstein, & David C. Metz. (2006). Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture. JAMA. 296(24). 2947–2947. 914 indexed citations breakdown →

13.

Metz, David C.. (2004). Managing gastroesophageal reflux disease for the lifetime of the patient: Evaluating the long-term options. PubMed. 117(5). 49–55. 19 indexed citations

14.

Metz, David C., et al.. (2002). Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis. Alimentary Pharmacology & Therapeutics. 17(1). 155–164. 22 indexed citations

15.

Levine, Marc S., et al.. (2002). Achalasia: a disease of varied and subtle symptoms that do not correlate with radiographic findings. The American Journal of Gastroenterology. 97(8). 1916–1923. 43 indexed citations

16.

Metz, David C., Vijaya S. Pratha, Patrick Martin, et al.. (2000). Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease. The American Journal of Gastroenterology. 95(3). 626–633. 42 indexed citations

17.

Lewis, James D., Edward J. Shin, & David C. Metz. (2000). Characterization of gastrointestinal bleeding in severely ill hospitalized patients. Critical Care Medicine. 28(1). 46–50. 57 indexed citations

18.

Metz, David C.. (2000). Potential Uses of Intravenous Proton Pump Inhibitors to Control Gastric Acid Secretion. Digestion. 62(2-3). 73–81. 27 indexed citations

19.

Lipson, David A., Jesse A. Berlin, Harold I. Palevsky, et al.. (1998). Giant Gastric Ulcers and Risk Factors for Gastroduodenal Mucosal Disease in Orthotopic Lung Transplant Patients. Digestive Diseases and Sciences. 43(6). 1177–1185. 11 indexed citations

20.

Talkad, Venugopal D., et al.. (1994). Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1224(1). 103–116. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact